Trademark: 85876328
Word
CANCER
Status Date
Monday, September 12, 2016
Filing Date
Thursday, March 14, 2013
Published for Opposition
Tuesday, June 11, 2013
Abandoned Date
Monday, September 12, 2016
5 Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
42 Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
44 Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
45 Government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, including counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith
The color(s) blue, red and white is/are claimed as a feature of the mark.
The mark consists of a red universal prohibition symbol with a blue and white globe inside and the word "CANCER" in white with a red line diagonally through it.
Sep 12, 2016
Abandonment Notice Mailed - No Use Statement Filed
Sep 12, 2016
Abandonment - No Use Statement Filed
Jan 22, 2016
Notice Of Approval Of Extension Request E-Mailed
Jan 21, 2016
Extension 5 Granted
Dec 29, 2015
Extension 5 Filed
Dec 29, 2015
Teas Extension Received
Jul 28, 2015
Teas Change Of Correspondence Received
Jul 10, 2015
Notice Of Approval Of Extension Request E-Mailed
Jul 9, 2015
Extension 4 Granted
Jun 30, 2015
Extension 4 Filed
Jun 30, 2015
Teas Extension Received
Jan 27, 2015
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2015
Extension 3 Granted
Jan 5, 2015
Extension 3 Filed
Jan 5, 2015
Teas Extension Received
Aug 6, 2014
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2014
Extension 2 Granted
Jul 8, 2014
Extension 2 Filed
Aug 5, 2014
Case Assigned To Intent To Use Paralegal
Jul 8, 2014
Teas Extension Received
Jan 9, 2014
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2014
Extension 1 Granted
Jan 7, 2014
Extension 1 Filed
Jan 7, 2014
Teas Extension Received
Aug 6, 2013
Noa E-Mailed - Sou Required From Applicant
Jun 11, 2013
Official Gazette Publication Confirmation E-Mailed
Jun 11, 2013
Published For Opposition
May 22, 2013
Notification Of Notice Of Publication E-Mailed
May 4, 2013
Law Office Publication Review Completed
May 4, 2013
Assigned To Lie
Apr 24, 2013
Approved For Pub - Principal Register
Apr 24, 2013
Teas/Email Correspondence Entered
Apr 24, 2013
Correspondence Received In Law Office
Apr 24, 2013
Teas Response To Office Action Received
Apr 24, 2013
Notification Of Examiner's Amendment/Priority Action E-Mailed
Apr 24, 2013
Examiner's Amendment/Priority Action E-Mailed
Apr 24, 2013
Combined Examiner's Amendment/Priority Action Automatic Entry
Apr 24, 2013
Examiners Amendment And/Or Priority Action - Completed
Apr 23, 2013
Notification Of Examiner's Amendment/Priority Action E-Mailed
Apr 23, 2013
Examiner's Amendment/Priority Action E-Mailed
Apr 23, 2013
Combined Examiner's Amendment/Priority Action Automatic Entry
Apr 23, 2013
Examiners Amendment And/Or Priority Action - Completed
Apr 17, 2013
Assigned To Examiner
Mar 21, 2013
Notice Of Design Search Code E-Mailed
Mar 20, 2013
New Application Office Supplied Data Entered In Tram
Mar 18, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
